Biotechnology Stocks I Performance Guide: ACADIA Pharmaceuticals Inc. (ACAD)
ACAD has no dividends.
Table and Chart of ACAD Performance
See what a $1,000 investment in ACAD is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| ACAD Returns | |
|---|---|
| Start Date | Jul-31-2014 |
| Start Price | $20.27 |
| End Date | Jul-26-2024 |
| End Price | $19.14 |
| # Prices | 121 |
| Min Date | Jun-30-2022 |
| Min Price | $14.09 |
| Max Date | Nov-30-2020 |
| Max Price | $56.66 |
| Total Return | -5.57% |
| Annualized Return | -0.57% |
| Current Value of $1,000 Purchase | $944 |
| Number Returns | 7,260 |
| Average Return | -4.05% |
| Number Profitable Returns | 2,715 |
| Percent Profitable Returns | 37.40% |
| Number Unprofitable Returns | 4,545 |
| Percent Unprofitable Returns | 62.60% |
| Profitable to Unprofitable Returns Ratio | 0.60 |
| ACAD Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $3,064,849,000 |
| Beta | 0.381 | Price to Sales | 3.89 |
| Earnings per Share | $0.0000 |
| PE Ratio | 0 |
| PE to Growth Ratio | -0.42 |
| Price to Book | 6.54 |
| PRICE DATA | |
| 52 Week High | $32.59 |
| 52 Week Low | $14.55 |
| Analyst Target Price | $27.32 |
| 50-Day Moving Average | $16.02 |
| 200-Day Moving Average | $21.19 |
| FINANCIAL DATA | |
| Revenue per Share | $4.949 |
| Revenue | $813,806,000 |
| Profit Margin | -0.21% |
| Return on Equity | -0.41% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
ACAD Compare Returns with S&P 500
ACAD Trendline Chart
ACAD Moving Average Chart
ACAD Stock Return Map - See Patterns of Gains and Losses
ACAD Stock Returns/Purchase Dates